Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Europe’s first dedicated biobank stores cells from endangered animals
Nature's SAFE uses a specialised cryopreservation media to indefinitely store live skin cells from threatened species.

Charity launched in response to dramatic decline in global biodiversity

A 'ground-breaking' new charity inspired by advanced equine reproduction technology has been launched with the goal of preserving endangered species.

Nature's SAFE is Europe's first 'living biobank'. It will process and store skin and reproductive cells from endangered species, which can then be used in regeneration of animals and restoration of species.

Founder Tullis Matson – who is also managing director of Stallion AI Services, a UK based centre of excellence for equine reproduction – realised that the same techniques developed for equines could be used in conservation by storing live cells from endangered species.

“To be able to use 30 years of experience in equine reproduction and equine rare breed preservation for an even greater good is a real privilege,” said Mr Matson.

“It is an honour to be working with some of the world’s most endangered species and knowing that we are saving such important animals is indescribable.”

The charity uses a specialised processing technique, freezing the skin cells of threatened species at a temperature of -196°C. They are then preserved in a dormant state and can be kept indefinitely and once thawed they can be used in animal artificial reproduction programmes.

Nature’s SAFE will also store ovarian and testicular tissue from endangered animals, and it plans to develop new techniques to generate sperm and egg cells from reproductive tissue.

Dr Sue Walker, Nature's SAFE co-Founder and vice chair, head of science at Chester Zoo, chair of the EAZA Reproductive Management Group and Board Member of the EAZA Biobank said: “The cryopreservation of reproductive cells and cell lines will be an important tool for population breeding programmes and the restoration of genetic diversity in animal species threatened with extinction.

“Having a facility solely dedicated to preserving these samples, Nature’s SAFE is a vital tool missing from the European zoo conservation toolbox.”

Nature’s SAFE has already successfully stored live cells from multiple endangered species through collaboration with their partners in the national zoo association. These species include the black rhino, Asian elephant, eastern bongo and Javan green magpie.

For more information on Nature's SAFE, or to support it's work, please visit https://www.natures-safe.com

Image (c) Nature's SAFE.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.